|
| 36967330 | Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria, Swiss AGO, BGOG, CEEGOG, GEICO, and SFOG regarding the use of hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancer. | Bull Cancer | 2024 |
| 37231277 | Changes in the rate of preterm infants during the COVID-19 pandemic Lockdown Period-data from a large tertiary German University Center. | Arch Gynecol Obstet | 2024 |
| 36320156 | Pelvic inlet area is associated with birth mode. | Acta Obstet Gynecol Scand | 2023 |
| 37585293 | Protocol to optimize the biobanking of ovarian cancer organoids by accommodating patient-specific differences in stemness potential. | STAR Protoc | 2023 |
| 37636837 | Clinical relevance of potential self-medication drug interactions in antineoplastic and immune-modulating therapy among online pharmacy customers. | Ther Adv Drug Saf | 2023 |
| 35751684 | Expression pattern and prognostic potential of histamine receptors in epithelial ovarian cancer. | J Cancer Res Clin Oncol | 2023 |
| 37422672 | Clear cell endometrial carcinoma with high microsatellite instability in a complicated pregnancy: a case report. | J Med Case Rep | 2023 |
| 37087046 | Amniotic fluid embolism: A comparison of two classification systems in a retrospective 8-year analysis from two tertiary hospitals. | J Gynecol Obstet Hum Reprod | 2023 |
| 36989681 | Updates of placental macrophages: Origins, molecular markers, functions, and related diseases. | J Reprod Immunol | 2023 |
| 37402882 | Amyloid-like p53 as prognostic biomarker in serous ovarian cancer-a study of the OVCAD consortium. | Oncogene | 2023 |
| 37369376 | European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer - Update 2023. | Int J Gynecol Cancer | 2023 |
| 37101223 | MSX1-expression during the different phases in healthy human endometrium. | Arch Gynecol Obstet | 2023 |
| 37001891 | Quality of therapy in early ovarian cancer: results of the quality assurance program of the AGO Study Group. | Int J Gynecol Cancer | 2023 |
| 37199905 | KLF11 is an independent negative prognostic factor for breast cancer from a cohort study and induces proliferation and inhibits apoptosis in vitro. | Breast Cancer | 2023 |
| 37000264 | Pazopanib with Topotecan weekly for patients with platinum-resistant or intermediate-sensitive recurrent ovarian cancer: results of a multicentre, open label phase I/II study (TOPAZ). | J Cancer Res Clin Oncol | 2023 |
| 37131060 | Nuclear receptor co-repressor NCOR2 and its relation to GPER with prognostic impact in ovarian cancer. | J Cancer Res Clin Oncol | 2023 |
| 36997987 | Publisher Correction: The psychological burden of COVID-19 on the desire for parenthood in minoritized sexual identities: a study on depressive symptoms and family planning in Germany. | BMC Public Health | 2023 |
| 37197430 | RIPK1 and RIPK3 are positive prognosticators for cervical cancer patients and C2 ceramide can inhibit tumor cell proliferation <i>in vitro</i>. | Front Oncol | 2023 |
| 36878560 | Integrating antibody drug conjugates in the management of gynecologic cancers. | Int J Gynecol Cancer | 2023 |
| 36648484 | Sialyl Lewis X mediates interleukin-1 beta-induced trophoblast adhesion to endometrial cells during human embryo implantation. | Biol Reprod | 2023 |
| 36614323 | PLA2G7/PAF-AH as Potential Negative Regulator of the Wnt Signaling Pathway Mediates Protective Effects in BRCA1 Mutant Breast Cancer. | Int J Mol Sci | 2023 |
| 36436093 | Prostaglandin E2 receptor EP1 expression in vulvar cancer. | J Cancer Res Clin Oncol | 2023 |
| 36538164 | Lower HLA-G levels in extravillous trophoblasts of human term placenta in gestational diabetes mellitus than in normal controls. | Histochem Cell Biol | 2023 |
| 36640674 | Obesity in pregnancy is associated with macrophage influx and an upregulated GRO-alpha and IL-6 expression in the decidua. | J Reprod Immunol | 2023 |
| 36769131 | Expression of Progesterone Receptor A as an Independent Negative Prognosticator for Cervical Cancer. | Int J Mol Sci | 2023 |
| 36707086 | PARP inhibitors: risk factors for toxicity and matching patients to the proper poly (ADP-ribose) polymerase inhibitor (PARPi) therapy. | Int J Gynecol Cancer | 2023 |
| 36732703 | The psychological burden of COVID-19 on the desire for parenthood in minoritized sexual identities: a study on depressive symptoms and family planning in Germany. | BMC Public Health | 2023 |
| 36703076 | Publisher Erratum: Langer Leidensweg bei Endometriose. | MMW Fortschr Med | 2023 |
| 36599181 | tRNA-derived small RNA 3'U-tRF<sup>ValCAC</sup> promotes tumour migration and early progression in ovarian cancer. | Eur J Cancer | 2023 |
| 36792811 | Increase of the T-reg-recruiting chemokine CCL22 expression in a progressive course of cervical dysplasia. | J Cancer Res Clin Oncol | 2023 |
| 36482113 | Risk of postpartum depressive symptoms is influenced by psychological burden related to the COVID-19 pandemic and dependent of individual stress coping. | Arch Gynecol Obstet | 2023 |
| 36068443 | High RIG-I and EFTUD2 expression predicts poor survival in endometrial cancer. | J Cancer Res Clin Oncol | 2023 |
| 36068363 | Trends among patients with endometriosis over a 7-year period and the impact of the COVID-19 pandemic: experience from an academic high-level endometriosis centre in Germany. | Arch Gynecol Obstet | 2023 |
| 36332161 | Optimal Treatment Duration of Bevacizumab as Front-Line Therapy for Advanced Ovarian Cancer: AGO-OVAR 17 BOOST/GINECO OV118/ENGOT Ov-15 Open-Label Randomized Phase III Trial. | J Clin Oncol | 2023 |
| 34739585 | Role of FoxP3-positive regulatory T-cells in regressive and progressive cervical dysplasia. | J Cancer Res Clin Oncol | 2022 |
| 35843132 | The Pregnancy Zone Protein (PZP) is significantly downregulated in the placenta of preeclampsia and HELLP syndrome patients. | J Reprod Immunol | 2022 |
| 35805111 | CCL22-Polarized TAMs to M2a Macrophages in Cervical Cancer In Vitro Model. | Cells | 2022 |
| 35406491 | MUC1 (CA27.29) before and after Chemotherapy and Prognosis in High-Risk Early Breast Cancer Patients. | Cancers (Basel) | 2022 |
| 35837404 | Targeting Aberrantly Elevated Sialyl Lewis A as a Potential Therapy for Impaired Endometrial Selection Ability in Unexplained Recurrent Miscarriage. | Front Immunol | 2022 |
| 35377045 | Galectin-8 and -9 as prognostic factors for cervical cancer. | Arch Gynecol Obstet | 2022 |
| 35764443 | Clinical outcome of combined intracavitary / interstitial brachytherapy using a hybrid applicator in locally advanced cervical cancer. | Gynecol Oncol | 2022 |
| 35729354 | Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer. | J Cancer Res Clin Oncol | 2022 |
| 35468527 | Overexpression of galectin-4 in placentas of women with gestational diabetes. | J Reprod Immunol | 2022 |
| 35370105 | The Impact of the COVID-19 Pandemic on Sexual Health in Cis Women Living in Germany. | J Sex Med | 2022 |
| 35625634 | Gal-2 Increases H3K4me<sup>3</sup> and H3K9ac in Trophoblasts and Preeclampsia. | Biomolecules | 2022 |
| 35563052 | Regulatory T Cells with Additional COX-2 Expression Are Independent Negative Prognosticators for Vulvar Cancer Patients. | Int J Mol Sci | 2022 |
| 35682791 | Isolation of Decidual Macrophages and Hofbauer Cells from Term Placenta-Comparison of the Expression of CD163 and CD80. | Int J Mol Sci | 2022 |
| 36970052 | <i>Ad hoc</i> Analysis of the Phase III ENGOT-OV16/NOVA Study: Niraparib Efficacy in Germline <i>BRCA</i> Wild-type Recurrent Ovarian Cancer with Homologous Recombination Repair Defects. | Cancer Res Commun | 2022 |
| 36510075 | [Endometriosis - a seriously understimated disease]. | MMW Fortschr Med | 2022 |
| 36600507 | Interviews conducted at the European Society of Gynaecological Oncology 2022 Congress: a ENYGO-IJGC Fellows initiative. | Int J Gynecol Cancer | 2022 |